目录号: A10295
mTOR 抑制剂
Deforolimus(Ridaforolimus)是一种处于研究阶段的靶向性小分子抑制剂,其作用目标是蛋白质 mTOR。通过阻断 mTOR,可以在癌细胞中产生类似饥饿的效果,这种效果通过干扰细胞的生长、分裂、代谢和血管生成来实现。
顾客使用 Adooq 产品发表的高质量科研文献
生物活性
Discription | Deforolimus (Ridaforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR. Blocking mTOR creates a starvation-like effect in cancer cells by interfering with cell growth, division, metabolism, and angiogenesis. |
||
---|---|---|---|
Targets |
|
产品信息
目录号 | A10295 |
---|---|
分子式 | C53H84NO14P |
分子量 | 990.2 |
CAS号 | 572924-54-0 |
SMILES | C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OP(=O)(C)C)C)/C)O)OC)C)C)/C)OC |
其他名称 | AP23573, MK-8669 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
In vitro (25°C) | DMSO | 196 mg/mL (197.93 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+40% PEG 300+5% Tween 80+50% H2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Preparing Stock Solutions
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 10.1 mL | 50.49 mL | 100.99 mL |
0.5 mM | 2.02 mL | 10.1 mL | 20.2 mL |
1 mM | 1.01 mL | 5.05 mL | 10.1 mL |
5 mM | 0.2 mL | 1.01 mL | 2.02 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 Deforolimus (Ridaforolimus) | Deforolimus (Ridaforolimus) 供应商 | Deforolimus (Ridaforolimus) 花费 | Deforolimus (Ridaforolimus) 生产商 | 订购 Deforolimus (Ridaforolimus) | Deforolimus (Ridaforolimus) 代理商
| 购买 572924-54-0 | 572924-54-0 供应商 | 572924-54-0 花费 | 572924-54-0 生产商 | 订购 572924-54-0 | 572924-54-0 代理商